Abiopharma

Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers

PRGO CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Perrigo Company plc

Q & M Dental Group (Singapore) Limited - Announcement

Henlius und Organon geben die Zulassung von POHERDY® (Pertuzumab-dpzb) durch die US-amerikanische Arzneimittelbehörde FDA bekannt, dem ersten PERJETA (Pertuzumab)-Biosimilar in den USA

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit

Henlius e Organon anunciam aprovação do POHERDY® (pertuzumabe-dpzb) pela FDA, o primeiro biossimilar de PERJETA (pertuzumabe) nos EUA

Henlius y Organon anunciaron que la Administración de Alimentos y Medicamentos de los Estados Unidos aprobó POHERDY ® (pertuzumab-dpzb), el primer biosimilar de PERJETA (pertuzumab) en los EE. UU.

Henlius en Organon kondigen goedkeuring door de Amerikaanse FDA aan van POHERDY® (pertuzumab-dpzb), de eerste PERJETA (pertuzumab) biosimilar in de VS

AdaptHealth Corp. Announces Upgraded S&P Global Issue-Level Rating on Senior Unsecured Debt

PRGO CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Perrigo Company plc Shareholders